27, Jun 2024
Mashman Consulting Group’s New Focus on Public Figures
Little Rock, AR, June 27, 2024 –Mashman Consulting Group (MCG), a leading consulting firm specializing in personal branding and individual reputation management, is excited to announce its revised marketing message: “We help public figures optimize and scale their personal brands.” This new focus highlights MCG’s dedication to working with qualified and ambitious individuals who are ready to adopt a macro approach to their success and personal reputations.
Previously, MCG’s mission was to “create, maintain, and scale unrivaled personal brands.” This change underscores a refined commitment to helping clients not just build a personal brand but position themselves as public figures — individuals worth following and emulating.
Isaac Mashman, founder of Mashman Consulting Group, shared his insights on this strategic shift: “I have been searching for depth in my work, often reflecting on what is the key to a successful personal brand, outside of the common knowledge points. I have concluded the ‘master key,’ if you will, is positioning yourself as a public figure. As someone worth following. This is how we will help our clients cut through the noise.”
MCG’s comprehensive approach includes personalized consulting services that assist public figures in optimizing their visibility, enhancing their reputations, and scaling their influence across various platforms. This change in the company’s mission ensures that MCG remains at the forefront of the personal branding industry, providing clients with cutting-edge consulting and strategies.
- 0
- By Rabindra
27, Jun 2024
CV Designer Crafting Professional Resumes for a Brighter Career
Chennai, India, June 27, 2024 — CV Designer – India’s Top Resume Writer, a leading provider of professional resume writing services, is proud to announce the launch of its comprehensive suite of resume writing solutions. With over 18 years of experience, CV Designer has helped thousands of individuals achieve their career goals by crafting compelling resumes that showcase their skills and experience in a clear and concise manner.
What Sets CV Designer Apart?
Experienced and Professional Writers: CV Designer’s team of experienced and professional writers have a deep understanding of the current job market and what recruiters are looking for. They are skilled at crafting resumes that are tailored to each individual’s unique background and career goals.
High-Quality Resumes: CV Designer’s resumes are designed to be visually appealing and easy to read. They use a variety of fonts, colors, and graphics to make your resume stand out from the competition.
Free Resume Review: CV Designer offers a free resume review to help you identify areas for improvement. This is a valuable service that can help you ensure that your resume is the best it can be.
100% Satisfaction Guarantee: CV Designer is so confident in its services that they offer a 100% satisfaction guarantee. If you are not happy with your resume, they will revise it for free until you are satisfied.
CV Designer’s Services:
CV Writing: CV Designer can help you create a professional CV that highlights your skills and experience. They offer a variety of CV formats to choose from, including chronological, functional, and combination CVs.
Cover Letter Writing: CV Designer can also help you write a compelling cover letter that will grab the attention of recruiters.
LinkedIn Profile Writing: CV Designer can help you create a LinkedIn profile that is optimized for search engines and showcases your professional brand.
Resume Design: CV Designer can help you design a visually appealing resume that will make a lasting impression on recruiters.
About CV Designer
CV Designer is a professional resume writing company that has been helping individuals achieve their career goals for over 18 years. They offer a variety of resume writing services, including CV writing, cover letter writing, and LinkedIn profile writing. They also offer a free resume review and a 100% satisfaction guarantee.
27, Jun 2024
Dr. Stefie Deeds Featured in New York Times Article on Innovative Obesity Treatment Approach
Seattle, WA, June 27, 2024 –Dr. Stefie Deeds, a Seattle-based internist and obesity medicine specialist, was recently featured in a New York Times article exploring the emerging “obesity first” approach to treating chronic diseases. The article, published on June 18, 2024, highlights how treating obesity with medications can lead to improvements in other health conditions.
Dr. Deeds, who runs a private practice in Seattle, is at the forefront of this innovative treatment approach. “We are treating the medical condition of obesity and its related complications at the same time,” Dr. Deeds explained in the article.
The New York Times piece prominently features one of Dr. Deeds’ patients who experienced significant improvements in her arthritis and high blood pressure after being prescribed Wegovy, a new obesity medication. She not only lost over 50 pounds but also found that her arthritis symptoms improved and she no longer needed blood pressure medication.
Dr. Deeds’ approach exemplifies a growing movement in obesity medicine that focuses on addressing obesity as a primary condition, rather than solely treating its related health issues separately. This method has shown promising results in improving various chronic conditions associated with obesity.
“Being featured by The New York Times for our approach to obesity treatment is a tremendous honor,” said Dr. Deeds. “It underscores the importance of considering obesity as a treatable medical condition that can have far-reaching effects on a patient’s overall health.”
27, Jun 2024
Kuna Sportswear Launches Wear the Adventure
Dover, DE, June 27, 2024 — Kuna Sportswear is proud to announce its official launch, bringing innovative and stylish outdoor apparel to adventure enthusiasts across the United States. Specializing in UPF 50+ sun protection clothing, Kuna Sportswear combines functionality with cutting-edge designs to inspire a lifestyle of exploration and adventure.
“Our mission at Kuna Sportswear is to empower individuals to embrace the spirit of adventure with apparel that seamlessly combines style with functionality,” said Andre Moya, Founder of Kuna Sportswear. “We are excited to introduce our range of high-performance clothing designed to keep you protected and comfortable during your outdoor pursuits.”
Kuna Sportswear offers a variety of products, including long sleeve shirts, quick dry shirts and shorts, all crafted with premium materials to ensure durability and comfort. The brand is committed to creating a community-driven experience, encouraging customers to push their limits and discover the outdoors.
Each piece of apparel is designed with the modern adventurer in mind. The flagship UPF 50+ long sleeve shirts provide superior sun protection, making them ideal for fishing, hiking, and other outdoor activities. These shirts are made from lightweight, breathable fabric that wicks away moisture, ensuring that you stay cool and comfortable even on the hottest days. The bold, fashionable designs set Kuna Sportswear apart, offering both style and practicality in one package.
Kuna Sportswear is more than just a clothing brand; it’s a movement aimed at fostering a community of like-minded individuals who share a passion for adventure and exploration. “We want our customers to feel inspired to explore new horizons, push their boundaries, and live a life full of adventure,” added Andre Moya. “Our clothing is a reflection of this spirit, combining the latest fabric technology with innovative design to meet the needs of outdoor enthusiasts.”
In addition to launching its online store, Kuna Sportswear is preparing to kick off a Kickstarter campaign to further expand its reach and product offerings. This campaign will provide backers with exclusive discounts and early access to new designs, reinforcing the brand’s commitment to community and innovation.
As part of its launch, Kuna Sportswear is also focusing on sustainability and ethical production practices. The company aims to minimize its environmental impact by using eco-friendly materials and ensuring fair labor practices in its manufacturing processes. This dedication to ethical practices aligns with the brand’s core values of inclusivity, resilience, and adventure-driven excellence.
27, Jun 2024
Announcing 2024 Counter Insider Threat Symposium
Washington, DC, June 27, 2024 — Defense Strategies Institute is pleased to announce the 9th Annual Counter Insider Threat Symposium, taking place at the Sunset Room in Washington, D.C. on September 4-5, 2024. The Symposium will bring together leaders and experts across government and industry to discuss the current insider threat environment, as well as the technologies and policies necessary to disrupt and dismantle those threats and safeguard sensitive information vital to maintaining national security.
As organizations continue to face data breaches and unauthorized disclosures because of insider threats, it has become increasingly important to ensure sufficient investments are being made in advanced counter insider threat programs. Organizations must look at behavioral, financial, and cultural indicators in addition to implementing adequate data security measures. Attendees will hear from leaders and experts about the need for the development and implementation of a robust counter insider threat strategy across the public and private sectors.
The Symposium will feature high-level speakers including:
· Michael C. Casey- Director, NCSC
· Don Carlos James Blasingame- Director, National Insider Threat Task Force
· Richard D. McComb, SES- Chief Security Officer, DHS
· David Helfen- Sr. Director, Insider Threat & Cyber Investigations, Visa
· Jacqueline Atiles- Director, Insider Threat Program, Department of State
· Dr. Deanna D. Caputo- Chief Scientist & Senior Principal Behavioral Psychologist, MITRE
· Randy Trzeciak- Technical Manager/Director MSISPM Program, Carnegie Mellon University
· J.T. Mendoza- Executive Director, US Insider Risk Management COE
· Victor Munro- Executive Director, Canadian Insider Risk Management Centre of Excellence
Topics to be covered at the 2024 Symposium:
· Advancing Counterintelligence & Enterprise Capabilities through Strategic Partnerships
· Preventing Insider Risk at State Department through Deterrence, Detection, and Mitigation
· Leveraging Behavioral Sciences to Mitigate and Manage Insider Risk
· Delivering Enterprise-Wide Security Solutions for DHS to Protect Against Evolving Threats
· Leveraging Data Analytics to Enhance Insider Risk Management
DSI is now welcoming Sponsors and Exhibitors for the forum. Reserve your spot to showcase your organization’s cutting-edge technologies to attendees from DoD, Military Services, and Industry. To learn more please contact Dudley Duverne at dduverne@dsigroup.org, 201-987-1803.
27, Jun 2024
Daicel Arbor Biosciences Launches New myTXTL Kits to Accelerate Protein Expression
Ann Arbor, MI, June 27, 2024 — Daicel Arbor Biosciences is excited to announce the release of the next generation of its myTXTL® kits, for cell-free protein expression, designed to simplify and accelerate antibody discovery and protein engineering. These powerful new kits include the myTXTL Pro Kit and the myTXTL Antibody/DS Kit, providing researchers with versatile tools to enhance throughput of their protein expression platforms, bringing discovery programs in both industry and academia to new heights.
The myTXTL Pro Kit offers researchers a high yield solution for expression of non-disulfide bond-containing proteins and combines all the benefits of their previous kit offerings into one box for a simpler go-to solution. Whether you want to perform a simple library screen, CRISPR-Cas activity assays, or test gene circuits, the Pro Kit can serve multiple purposes in protein expression and synthetic biology.
In addition, the myTXTL Antibody/DS Kit is designed for robust expression of antibodies and disulfide bond-containing proteins, while also providing expression of proteins without disulfide bonds. It enables simple and scalable production of high-quality antibodies and other proteins, empowering researchers to explore diverse applications in biologics development, antibody screening, and protein engineering.
“The release of these kits marks a significant advancement in cell-free protein expression technology. Researchers can now produce analysis-ready yields of antibodies or target proteins within hours, simply by adding DNA,” said Alison Devault, Ph.D., Director of Product Management at Daicel Arbor Biosciences. “We are eager to collaborate with our customers to help them achieve their project objectives.”
Designed with the user in mind, the myTXTL kits offer a streamlined and intuitive workflow, eliminating technical barriers and accelerating experimental timelines. These user-friendly features enable researchers to get their data sooner and drive innovation, confident in the robustness and reliability that these kits provide.
The new myTXTL kits are now available for purchase, and Daicel Arbor Biosciences anticipates these kits to have a significant impact on antibody discovery, protein engineering, and synthetic biology research.
27, Jun 2024
Chameleon Kid A Colorful Journey A New Children’s Book by Stephen Lewis
Mount Dora, FL, June 27, 2024 — A new children’s book, “Chameleon Kid: A Colorful Journey,” is set to release on September 1, 2024. In this heartwarming tale, a boy’s black-and-white world is suddenly invaded by color. As he begins to interact with these colors, he learns about different emotions and discovers his true essence.
“Chameleon Kid: A Colorful Journey” is written and illustrated by Stephen Lewis, whose multi-faceted skillset has garnered him several awards (including Best Actor, Best Director, Best Production Design, Best Story, and Best Picture from Orlando Independent Filmmakers) and assisted him as he produced his one-man show, Lotus, at the Orlando International Fringe Festival.
Now, as the co-founder of Just Us Studio (along with actor and writer Brittany Abdizadeh), Stephen is bringing his unique vision and storytelling prowess to “Chameleon Kid: A Colorful Journey,” a project that started as a beloved short film, “Chameleon Kid,” recently featured at the Sunscreen Film Festival, and later led to a children’s series, “Chameleon Kids.”
27, Jun 2024
Chetu Wins Gold for Information Technology Software Company of the Year from the Golden Bridge Awards
Sunrise, FL, June 27, 2024 — Chetu, a leading global software solutions and support services provider, proudly announces that it has been named the gold winner for Company of the Year in Information Technology Software by the prestigious 16th Annual 2024 Golden Bridge Awards®.
“We are thrilled the Golden Bridge Awards® have honored us as the Company of Year for Information Technology Software,” said Atal Bansal, Founder and CEO of Chetu. “This award reflects our team’s dedication, creativity, and hard work and reinforces our goal to provide exceptional service to our clients.”
The Golden Bridge Awards® are an annual industry and peer recognition program honoring the best companies and individuals in every major industry worldwide. The awards highlight outstanding organizations, products, and people who have made significant contributions and set new standards of excellence.
“Congratulations to all the winners of the Golden Bridge Awards for your remarkable innovations and outstanding business achievements,” said San Madan, President of Globee Awards, which sponsors the Golden Bridge Awards®. “Your dedication to excellence and groundbreaking contributions are setting new standards and inspiring others across the globe.”
This is Chetu’s fifth Globee Award®, having received a Gold honor earlier this week for Achievement in Technology in the American Business Awards. Chetu has also been recognized with Gold Globees in Business Excellence and American Best in Business, along with a Silver award in the Golden Bridge Awards®. Additionally, Chetu won a 2024 Silver Stevie® Award in the American Business Awards® and was named to CRN’s 2024 Solution Provider 500 and Tech Elite lists. The company has also been a member of the invite-only Forbes Technology Council for the past six years.
27, Jun 2024
Frequent flyers facing sudden hearing loss disorder in India
Mumbai- Sudden Sensorineural Hearing Loss SNHL can strike anybody, even the healthy physique, with no apparent warning as per medical experts in Mumbai. Well-known playback singer Alka Yagnik recently revealed that she has been diagnosed with a rare form of hearing loss, a disorder which has forced her to cancel all her concerts. Loud noise, smoking, alcohol consumption, comorbidities like diabetes, autoimmune disorders like arthritis, and cancer drugs can also impair hearing suddenly. Change in the middle ear pressure while scuba diving or flying (frequent flyers) can damage the inner ear, causing sudden but temporary deafness. If this happens repeatedly, deafness can become permanent. Giving more information on this Dr. Binhi Desai ENT and Voice Surgeon- Otorhinolaryngologist, Founder of ‘SWAR Voice and Swallowing clinic’ at Apex Superspeciality Hospital, Borivali, says, Viral Sudden onset Sensorineural Hearing Loss ( SSNHL) is an ENT emergency condition, which is characterized by rapid onset of hearing loss or a progressive loss over 12-24 hours. Certain viruses such as herpes simplex virus (HSV), herpes zoster virus(HZV), HIV, hepatitis virus, measles virus, rubella virus, mumps virus, Lassa virus, and enterovirus are commonly associated with the condition. During the COVID pandemic, there were many cases of sudden onset sensorineural hearing loss. The incidence of SSNHL is 5 to 20 cases per 100,000 people per year. The patient complains of sudden onset hearing loss over 12-24 hours.
Dr. Binhi Desai ENT and Voice Surgeon further added, it can be unilateral or bilateral. One must visit an ENT surgeon at the earliest, since 72 hours is a golden period. Results are better if treatment is started within the first 1-2 weeks. There are multiple treatment options available. The treatment is mainly in the form of steroids, vasodilators, anti-viral, antibiotics. Intra- tympanic steroid injection is a novel technique and a very useful procedure which gives excellent results along with intravenous treatment. The prognosis is guarded. The earlier the treatment is started, the better is the prognosis. If the above treatment fails, hearing aids, cochlear implant and assistive hearing devices can be offered.
Apex Group of Hospitals is a chain of Hospitals managed and run by expert Medical Professionals with experience of 25 years. Currently Apex group of Hospitals manage more than 350+ beds and provide qualitative healthcare services to the people of Mumbai and surrounding areas. Apex Hospitals is located in Borivali, Kandivali & Mulund.
27, Jun 2024
QPS Announces New Laboratory Services for Clinical Trials and Cell Therapy Development
Newark, Del., United States
QPS, a leading global contract research organization (CRO), is pleased to announce new laboratory services capabilities. The central laboratory, leukopak cell therapy facility, and enhanced PBMC capabilities will complement existing bioanalysis, translational medicine and peripheral blood mononuclear cell (PMBC) laboratories and extend the current QPS full-service global CRO offerings.
QPS Missouri, a division of QPS Holdings, LLC, a global Contract Research Organization. QPS Missouri conducts Phase I-IV clinical trials and houses central lab, safety lab, PBMC and cell production services in Springfield, Missouri. (Photo: Business Wire)
QPS Missouri, a division of QPS Holdings, LLC, a global Contract Research Organization. QPS Missouri conducts Phase I-IV clinical trials and houses central lab, safety lab, PBMC and cell production services in Springfield, Missouri. (Photo: Business Wire)
QPS now offers clinical trial sample analysis services and leukopak cell therapy products from its newly expanded clinical trials unit conveniently located in Springfield, Missouri. In addition, QPS has also expanded PBMC service offerings from its Miami, Florida location into its Springfield, Missouri laboratories. The new facilities are housed with an existing clinical (safety) laboratory, a modern self-contained pharmacy, and dedicated space to build and ship clinical trial kits.
The modern central laboratory for sample analysis complements the existing on-site safety laboratory, equipped with the most up-to-date technologies for chemistry, urinalysis, serology, coagulation, and hematology testing. These capabilities, designed to monitor subject safety during ongoing clinical trials, will remain as core services for QPS in-house clinical trials.
The new leukopak products collection and processing facility is designed to meet the exponential growing demand for blood products to support cell therapy research and QPS is ideally placed to provide this service. QPS Missouri has a database of over 35,000 potential study participants, who can be contacted as potential blood donors for leukopak products.
“There is significant unmet demand in this rapidly growing area of cell therapy products, which represents a tremendous opportunity for QPS. Over 3,000 cell and gene therapy programs are currently in progress representing a 20% increase over the past five years. These programs require leukopak products to move forward, and as a result this market is forecasted to grow by a CAGR of more than 8% over the next six years,” said Benjamin Chien, Chairman, President and CEO of QPS.
The enhanced PBMC services include a new PBMC processing lab at the Springfield location, complementing the existing lab at QPS Miami in Miami, Florida. This new lab will support a current unmet need for PBMC processing in the midwestern USA. PBMC sample analysis is a time-consuming process, typically required in vaccine trials, and it is best done in a lab adjacent to the clinical trial unit. QPS is uniquely positioned to offer this service.
“These new facilities, services and products extend our full service CRO capabilities, putting QPS in a position to offer clients comprehensive clinical research services in one location. The central lab, PBMC lab, and the leukopack facility complement and enhance our current 240 bed clinical trials unit, safety laboratory, modern self-contained pharmacy, and clinical trial kit production facility,” said Brendon Bourg, Vice President, Early Phase Clinical and Head of Administration at QPS Missouri.
